The roles of regulatory B cells in cancer

68Citations
Citations of this article
149Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Regulatory B cells (Bregs), a newly described subset of B cells, have been proved to play a suppressive role in immune system. Bregs can inhibit other immune cells through cytokines secretion and antigen presentation, which give them the role in the pathogenesis of autoimmune diseases and cancers. There are no clear criteria to identify Bregs; different markers were used in the different experimental conditions. Massive researches had described the functions of immune cells such as regulatory T cells (Tregs), dendritic cells (DCs), and B cells in the autoimmune disorder diseases and cancers. More and more researches focused on the roles of Bregs and the cytokines such as Interleukin-10 (IL-10) and transforming growth factor beta (TGF-β) secreted by Bregs. The aim of this review is to summarize the characteristics of Bregs and the roles of Bregs in cancer. © 2014 Yan He et al.

Cite

CITATION STYLE

APA

He, Y., Qian, H., Liu, Y., Duan, L., Li, Y., & Shi, G. (2014). The roles of regulatory B cells in cancer. Journal of Immunology Research. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/215471

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free